Tirzepatide 20mg – Research Peptide

Tirzepatide 20mg is supplied as a high-purity lyophilized synthetic peptide intended for laboratory research involving incretin receptor signaling and metabolic pathway analysis. In controlled research environments, this compound is studied for its interaction with GLP-1 and GIP receptor pathways.

We’ve published a detailed research comparison examining Retatrutide vs Tirzepatide in laboratory settings, including receptor targeting differences and signaling pathway considerations.

Read the full comparison here.

Research Applications

Tirzepatide is evaluated in research settings for:

• Dual incretin receptor pathway activation

• cAMP signaling dynamics

• Receptor coordination modeling

• Metabolic signaling pathway investigation

Its dual receptor targeting profile distinguishes it from triple-agonist compounds studied in related laboratory models.

Retatrutide

Product Specifications

• Compound: Tirzepatide

• Strength: 20mg per vial

• Form: Lyophilized powder

• Purity: Research-grade (see COA)

• Storage: Refrigerated conditions recommended

• Intended Use: Laboratory Research Use Only

Certificate of Analysis

Each vial includes a QR code linking to the current Certificate of Analysis for batch verification.

Current Active Batch:  #ERL-2501-B019-T

View Current COA

All materials are supplied strictly for laboratory research use only. Not for human or animal consumption.

Related Metabolic Research Peptides

Researchers studying Tirzepatide may also examine:

• Retatrutide 20mg – Research Peptide

• AOD-9604 5mg – Research Peptide

• MOTS-C 10mg – Research Peptide